Multiple Sclerosis News Today

Sensoready Pen easier to use for MS therapy than other devices: Survey

Both people with multiple sclerosis (MS) and their nurses prefer the Sensoready Pen for administering Kesimpta (ofatumumab) — an approved MS treatment that’s injected subcutaneously, or under the skin ...
The American Journal of Managed Care

Drug Prices to Continue Upward Trend Even as Biosimilars Enter the Market

Multiple adalimumab biosimilars will hit the US market in 2023, but the drug is still projected to have the largest price increase for the calendar year starting July 1. The overall drug price ...
Monthly Prescribing Reference

Medication Error Possible if Incompatible Autoinjector Used to Administer MS Drug

Senior patient talks about autoinjector with her doctor. Glatiramer acetate injection is indicated for the treatment of relapsing forms of multiple sclerosis. The Food and Drug Administration (FDA) ...
Yahoo Finance

Injectable Devices for Subcutaneous Self-administration Market Research Report 2022: Assess the Importance of Alliances and Partnerships on Subcutaneous Drug Product ...

Dublin, April 13, 2022 (GLOBE NEWSWIRE) -- The "Injectable Devices for Subcutaneous Self-administration to 2028" report has been added to ResearchAndMarkets.com's offering. Because of the ongoing need ...
Diabetes.co.uk

Visual Impairment

Diabetes is closely linked with a number of conditions that can impair vision, in particular, diabetic retinopathy. The good news is that identification and treatment of these eye problems is ...